Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial Senna W. M. LammersSandra M. E. Geurtson behalf of the Dutch Breast Cancer Research Group (BOOG) for the DATA investigators Research Open access 28 June 2024
Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: an ancillary study of JCOG0306 Tadahiko ShienHitoshi TsudaHiroji Iwata Research Open access 27 June 2024
First- vs second-line CDK 4/6 inhibitor use for patients with hormone receptor positive, human epidermal growth-factor receptor-2 negative, metastatic breast cancer in the real world setting Gretchen KimmickAsal PilehvariRoger Anderson Research Open access 26 June 2024
Understanding cardiac events in breast cancer (UCARE): pilot cardio-oncology assessment and surveillance pathway for breast cancer patients Michael CroninAoife LoweryOsama Soliman Methodology Open access 26 June 2024
Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial) Takayuki IwamotoNaoki NiikuraShigehira Saji Research 26 June 2024
Feasibility of risk assessment for breast cancer molecular subtypes Anne Marie McCarthySarah Ehsan**bo Chen Research Open access 25 June 2024
The clinical signature of genetic variants and serum levels of macrophage migration inhibitory factor in Egyptian breast cancer patients Mahmoud A. SeliemAhmed M. MohamadinAhmed A. El-Husseiny Research Open access 25 June 2024
Outcomes of older adults with early-stage triple-negative breast cancer (TNBC) receiving chemotherapy: a single-institution experience Akshara Singareeka RaghavendraDiane LiuMeghan Sri Karuturi Research 25 June 2024
SCARB2 associates with tumor-infiltrating neutrophils and predicts poor prognosis in breast cancer Dan ZhangJun FangQingqing Wang Preclinical study 24 June 2024
Identifying research priorities for improving information and support for patients undergoing breast cancer surgery: a UK patient-centred priority setting project Emma JohnstonKatherine CowanShelley Potter Research Open access 24 June 2024
Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States Kevin KalinskyLaura SpringRita Nanda Research Open access 21 June 2024
Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants Song WenMeng ZhangYuntao **e Research 20 June 2024
p53 protein expression patterns associated with TP53 mutations in breast carcinoma Sarah A. AndersonBrooke B. Bartow**ao Huang Research Open access 20 June 2024
Reliability of Magseed® marking before neoadjuvant systemic therapy with subsequent contrast-enhanced mammography in patients with non-palpable breast cancer lesions after treatment: the MAGMA study Eva Iglesias BravoAntonio Mariscal MartínezAnabel García Barrado Research Open access 20 June 2024
A novel role of IGFBP5 in the migration, invasion and spheroids formation induced by IGF-I and insulin in MCF-7 breast cancer cells Karem Rodríguez-RojasPedro Cortes-ReynosaEduardo Perez Salazar Research Open access 19 June 2024
Male breast cancer: a multicenter study to provide a guide for proper management Germana LissidiniLuca NicosiaViviana Galimberti Research 19 June 2024
BET-directed PROTACs in triple negative breast cancer cell lines MDA-MB-231 and MDA-MB-436 Maryana TeufelsbauerSandra SticklerGerhard Hamilton Research Open access 19 June 2024
Demographic and clinical characteristics of patients with metastatic breast cancer and leptomeningeal disease: a single center retrospective cohort study Laura A. HuppertSamantha FischMichelle E. Melisko Research Open access 18 June 2024 Pages: 625 - 636
Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14 Shogo NakamotoYukiko KajiwaraShinichi Toyooka Research 18 June 2024
Re: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium and the National Cancer Database (NCDB) P. NevenS. HanS. A. Khan Letter to the Editor 16 June 2024
Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer **n HuangChang ChenYidong Zhou Research Open access 15 June 2024 Pages: 653 - 666
Incidence of local breast cancer recurrence with delayed radiation therapy Hayder Hamza AlabediImad Khalid AhmedAhmed Sabah Mohammed Jamil Research 14 June 2024
Adherence to guideline recommendations for follow-up in patients with DCIS at a large teaching hospital in the Netherlands K. K. RajanJ. J. NijveldtA. B. Francken Research 14 June 2024
Patient-reported outcomes and quality of life after breast-conserving surgery, mastectomy, and breast reconstruction assessed using the BREAST-Q questionnaire Shoichi TomitaTakashi YoshitakeYasunobu Terao Research 14 June 2024
Ferroptosis as a promising targeted therapy for triple negative breast cancer Kasra MokhtarpourSepideh RaziNima Rezaei Review 14 June 2024
Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice Manali A. BhaveJulia C. F. QuintanilhaKevin Kalinsky Research Open access 14 June 2024
Spectrum of germline pathogenic variants in Brazilian hereditary breast/ovarian cancer cases João Paulo FariaJuliana Godoy AssumpçãoLuiz De Marco Research 14 June 2024
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer Christian JackischLouiza AnastasiadouMarc Thill Clinical trial Open access 14 June 2024
Tamoxifen modulates nutrition deprivation-induced ER stress through AMPK-mediated ER-phagy in breast cancer cells Biswas BidishaManickavasagan SowmyaSelvaraju Sudhagar Research 14 June 2024
UM171 suppresses breast cancer progression by inducing KLF2 **aojuan RanAnling HuYaacov Ben-David Research Open access 14 June 2024
The contribution of second primary cancers to the mortality of patients with a first primary breast cancer Elisabete GonçalvesFilipa FontesSamantha Morais Research Open access 13 June 2024
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer Josefien P. van OlmenA. Marjolein SchrijverIris M. C. van der Ploeg Research Open access 12 June 2024 Pages: 585 - 594
Letter to the editor: “Body composition measures as a determinant of alpelisib-related toxicity” Zeki Surmeli Letter to the Editor 10 June 2024 Pages: 677 - 677
A randomized controlled trial of shared decision-making treatment planning process to enhance shared decision-making in patients with MBC Gabrielle B. RocqueNoon EltoumSmita Bhatia Clinical trial Open access 10 June 2024 Pages: 483 - 493
Second primary non-breast cancers in young breast cancer survivors Bessie X. ZhangKristen D. BrantleyAnn H. Partridge Research 10 June 2024
Revolutionizing breast cancer Ki-67 diagnosis: ultrasound radiomics and fully connected neural networks (FCNN) combination method Yanfeng LiWengxing LongHui **e Research 09 June 2024
Frequency and characteristics of errors by artificial intelligence (AI) in reading screening mammography: a systematic review Aileen ZengNehmat HoussamiM. Luke Marinovich Review Open access 09 June 2024
De-escalating indications for excision when breast core needle biopsy returns fibroepithelial lesion—not further characterized Tahereh SoleimaniDavid EuhusLisa K. Jacobs Research 08 June 2024
Burden and trajectory of social needs after breast cancer diagnosis at a safety-net hospital Eileen C. HowardMara E. Murray HorwitzTracy A. Battaglia Research 08 June 2024
Choosing breast-conserving therapy or mastectomy and subpectoral implant breast reconstruction: implications for pectoralis major function Joshua M. LeonardisAdeyiza O. MomohDavid B. Lipps Research 08 June 2024
Expression of Concern to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition Chonggao YinHongli LiWeiyi Chen Editorial Expression of Concern 06 June 2024 Pages: 679 - 679
Beta-blocker use and breast cancer outcomes: a meta-analysis Oliver William ScottSandar TinTinJ. Mark Elwood Review Open access 05 June 2024 Pages: 443 - 463
Therapeutic impact of 18F-FDG PET/CT for initial staging in patients with clinical stage I and IIA, HER2-positive, or triple-negative breast cancer Chloé FrançoisAudrey MailliezAnaïs Olivier Research 05 June 2024
A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets for breast cancer Wenning ShiCong XuDao-Lai Zhang Research 04 June 2024
Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations Nora C. ElsonKaren WernkeBarbara A. Wexelman Clinical trial 01 June 2024
Characterization of time toxicity in older patients with metastatic breast cancer Swarali Y. AtrePamela R. SoulosMaryam B. Lustberg Research 31 May 2024
Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma María José Roca NavarroJose Mª Oliver GoldaracenaJosé Ignacio Sánchez Méndez Research Open access 30 May 2024 Pages: 561 - 573
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients Nerina C. van der MerweInes BuccimazzaJaco Oosthuizen Research Open access 30 May 2024
Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment? Maya LubarskyAlexandra E HernandezNeha Goel Epidemiology 29 May 2024 Pages: 509 - 517
Surgical marker navigation system in breast conserving surgery and excision of non-palpable lesions: first Spanish single-center experience Ángela Santana ValencianoSonia Rivas FidalgoJosé María Fernández Cebrián Research 28 May 2024